is 741 has been researched along with ceruletide in 2 studies
| Studies (is 741) | Trials (is 741) | Recent Studies (post-2010) (is 741) | Studies (ceruletide) | Trials (ceruletide) | Recent Studies (post-2010) (ceruletide) |
|---|---|---|---|---|---|
| 20 | 0 | 0 | 3,002 | 91 | 645 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akizuki, E; Ishihara, K; Liang, J; Matsuda, T; Matsumura, F; Nakano, S; Ogawa, M; Ohshiro, H; Okabe, K; Yamaguchi, Y | 2 |
2 other study(ies) available for is 741 and ceruletide
| Article | Year |
|---|---|
The novel carboxamide derivative IS-741 reduces neutrophil chemoattractant production by bronchoalveolar macrophages in rats with cerulein-induced pancreatitis complicated by sepsis.
Topics: Animals; CD18 Antigens; Ceruletide; Chemotaxis; Disease Models, Animal; Enzyme Inhibitors; Injections, Intravenous; Interleukin-8; Macrophage-1 Antigen; Macrophages, Alveolar; Male; Neutrophil Infiltration; Pancreatitis; Pyridines; Rats; Rats, Wistar; Sepsis | 1999 |
Novel carboxamide derivative (IS-741) attenuates lung injury in rats with cerulein-induced pancreatitis complicated by endotoxemia.
Topics: Acute Disease; Animals; Bronchoalveolar Lavage Fluid; Cells, Cultured; Ceruletide; Endotoxemia; Enzyme Inhibitors; Hemorrhage; Infusions, Intravenous; Interleukin-16; Lung; Lung Diseases; Macrophages; Male; Neutrophils; Pancreatitis; Phospholipases A; Pyridines; Rats; Rats, Sprague-Dawley | 1999 |